Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.
Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden
Not measurable for this profile:
Reconstructed positions
· 1-day change
Trading activity Jul 4, 2018 – Jun 12, 2026
Anders Bladh reported 65
transactions between Jul 4, 2018 and Jun 12, 2026. The buy and sell totals below count only
codes SACQ, SDIS.
Open-market buys (SACQ)
40.09M SEK 670.4K EUR
41 purchases on filepriced rows only
Open-market sales (SDIS)
13.76M SEK
6 sales on filepriced rows only
All reported transactions
65
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window
Events from filings
Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.
3 insiders bought XSpray Pharma AB (publ) shares worth 819,773 SEK between Jun 12, 2026 and Jun 18, 2026
Cluster buying
3 different insiders made 4 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.
3 insiders bought XSpray Pharma AB (publ) shares worth 819,773 SEK between Jun 12, 2026 and Jun 18, 2026
Total of the rows above: 819,773 SEK, in the currency the filings report.
Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.
3 reporting parties bought XSpray Pharma AB (publ) shares worth 10,496,231 SEK between Jul 3, 2024 and Jul 29, 2024
Cluster buying
3 different reporting parties made 4 open-market purchases of this company’s shares within a short window. We call them reporting parties rather than insiders because we cannot confirm that every one of them is an individual: registers also list parent companies, funds and holding companies. Each row below is one reported trade.
3 reporting parties bought XSpray Pharma AB (publ) shares worth 10,496,231 SEK between Jul 3, 2024 and Jul 29, 2024
Total of the rows above: 10,496,231 SEK, in the currency the filings report.
Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.
3 reporting parties bought XSpray Pharma AB (publ) shares worth 2,569,361 SEK between May 16, 2024 and Jun 4, 2024
Cluster buying
3 different reporting parties made 7 open-market purchases of this company’s shares within a short window. We call them reporting parties rather than insiders because we cannot confirm that every one of them is an individual: registers also list parent companies, funds and holding companies. Each row below is one reported trade.
3 reporting parties bought XSpray Pharma AB (publ) shares worth 2,569,361 SEK between May 16, 2024 and Jun 4, 2024
Total of the rows above: 2,569,361 SEK, in the currency the filings report.
Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.
6 insiders bought DistIT AB shares worth 564,470 SEK between Feb 22, 2023 and Mar 20, 2023
Cluster buying
6 different insiders made 6 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.
6 insiders bought DistIT AB shares worth 564,470 SEK between Feb 22, 2023 and Mar 20, 2023
Total of the rows above: 564,470 SEK, in the currency the filings report.
Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.
Anders Bladh bought 150,000 XSpray Pharma AB (publ) shares for 8,530,500 SEK on Jan 25, 2022
Large trade for this person
Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.
Anders Bladh bought 150,000 XSpray Pharma AB (publ) shares for 8,530,500 SEK on Jan 25, 2022
Total of the rows above: 1,222,098 SEK, in the currency the filings report.
Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.
Reported transactions
Price 0.00 is a real reported figure
on allotments, gifts and option exercises — not a missing number.
The 25 most recent rows are grouped into 19 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 65 on file in total.
How to read this listi
Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.
The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.
Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.
What is not counted herei
Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.
Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.